BioSpace News Archive

Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, announced its business update and year-end report for 2021.

Any damage or defect in any one of the four heart valves can lead to a form of valve regurgitation disorders.

Somatostatin is a protein that is naturally built in the body. The organs that usually contribute to the development of somatostatin are the hypothalamus, stomach, pancreas, and bowels.

Increased occurrence of various eye disorders across all worldwide locations is estimated to spur the demand opportunities in the global eye drop dispenser market during the assessment period of 2019 to 2029.

Fact.MR – A Market Research and Competitive Intelligence Provider: Chemotherapy-induced nausea and vomiting treatment options are in high demand due to the rising prevalence of cancer and increased adherence to chemotherapy medications.

Addex Therapeutics announced that it has increased its share capital from 49,272,952 to 65,272,952 through the issue of 16,000,000 new registered shares at a nominal value of CHF1 each to Addex Pharma S.A, its 100% wholly-owned subsidiary.

Brain is a peculiar organ, dealing with a massive load of instructions every day. Sometimes, it takes multiple inputs, like when the body is moving on a mountain road with many twists and turns.

Endoprosthesis are mechanical devices that can be implanted in human skeleton, cardiovascular system, nervous system, and peripheral vascular system.

Illumina, Inc., announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to assess the clinical value of comprehensive genomic profiling in cancer therapy options in patients with late-stage disease compared to use of current standard of care, including small panel tests.

Oslo, 3 February2022: Ultimovacs ASA, a clinical stage leader in immune stimulatory vaccines for cancer, announced it has completed treatment of the second dose cohort in the Phase I TENDU trial.